NEW YORK (GenomeWeb) – OneOme announced today that it has signed an agreement to offer its RightMed pharmacogenomic test in Canada through medication management firm ProZed Pharmacy Solutions.

Under the terms of the deal, OneOme's PCR-based RightMed test — which covers 22 genes in which variants are known to contribute to the effectiveness or safety of more than 340 drugs for more than 20 indications — will be exclusively available to ProZed customers at Northern Shores Pharmacy in North Bay, Ontario.